Phentermine vs semaglutide for weight loss — two drugs with different mechanisms, different risk profiles, and different evidence bases. TelosRX reviews both to help you understand what the research actually shows before speaking with a licensed provider.
Both medications reduce appetite. That's where the similarities end. Phentermine is a decades-old stimulant that works through the brain's adrenaline system. Semaglutide is a GLP-1 receptor agonist — a newer class that slows digestion, resets the hunger set point, and improves insulin sensitivity simultaneously.
Quick Comparison: Phentermine vs Semaglutide
| Feature | Phentermine | Semaglutide |
|---|---|---|
| Drug class | Sympathomimetic amine (stimulant) | GLP-1 receptor agonist |
| Mechanism | Releases norepinephrine, suppresses appetite centrally | Slows gastric emptying, reduces hunger, improves insulin sensitivity |
| FDA approval | FDA-approved for short-term weight management | FDA-approved (Wegovy) for chronic weight management |
| Administration | Daily oral tablet (30–37.5 mg) | Weekly subcutaneous injection (0.25–2.4 mg) |
| Average weight loss | 5–10% body weight | ~14.9% body weight (STEP 1 trial, 68 weeks) |
| Duration of use | Short-term (weeks to months) | Long-term chronic use |
| Compounded version | Not typically compounded | Yes — subject to medical approval by a licensed provider |
| Common side effects | Dry mouth, insomnia, elevated heart rate, jitters | Nausea, constipation, diarrhea, headache |
| Cardiovascular risk | Higher — contraindicated in active heart disease | Lower — cardiovascular-protective data in T2D trials |
How Each Medication Works
Phentermine: The Adrenaline Trigger
Phentermine triggers norepinephrine release in the hypothalamus — the brain's hunger control center. The result: appetite drops, energy rises. It's chemically related to amphetamines, which explains both its effectiveness and its risk profile.
The effect tends to fade. Most appetite suppression occurs in the first 4–12 weeks. Tolerance builds; dependency risk is real. That's why it was historically approved only for short-term use.
Semaglutide: The Gut-Brain Reset
Semaglutide mimics GLP-1, a hormone your gut naturally secretes after eating. It slows gastric emptying (food stays in your stomach longer), signals satiety to the brain, and improves how cells respond to insulin.
Unlike phentermine, semaglutide appears to reset the brain's food-reward system. Trial participants reported reduced cravings and changed food preferences — not just reduced hunger. For a full breakdown, see our guide on how GLP-1 works for weight loss.
Weight Loss Results: What the Evidence Shows
The STEP 1 trial of semaglutide 2.4 mg showed average weight loss of 14.9% of body weight over 68 weeks in adults with obesity, versus 2.4% in the placebo group, per the landmark 2021 New England Journal of Medicine publication. A 2025 comparative analysis published in PubMed Central confirmed semaglutide produced significantly greater weight reduction than liraglutide and older anti-obesity medications including phentermine-class drugs.
Phentermine trials are older and shorter. A systematic review found average losses of 3–5 kg over 2–12 weeks at 30–37.5 mg/day. Long-term data is limited because most trials matched the original short-term approval window.
- Faster short-term results: Phentermine can produce quick initial appetite suppression — useful as a motivational kickstart before longer-term therapy
- Greater total loss: Semaglutide consistently outperforms over 6–18 months in head-to-head comparisons
- Muscle preservation: Neither medication protects lean mass without active effort — see our piece on preserving muscle on GLP-1
Compounded semaglutide from a telehealth pharmacy like TelosRX uses the same active molecule as Wegovy and is subject to medical approval by a licensed provider. Compounded semaglutide is not FDA-approved. For details, see our guide on compounded semaglutide access via telehealth.
Side Effects and Safety Profile
Phentermine Side Effects
Dry mouth, insomnia, elevated heart rate, jitters, and anxiety are the most commonly reported. These tend to be front-loaded — worst in the first weeks, then fading. More serious cardiovascular events (elevated blood pressure, pulmonary hypertension, cardiac valve abnormalities) have been reported, particularly in combination formulations. People with a history of cardiovascular disease should not take phentermine.
Semaglutide Side Effects
Nausea is the most common complaint — typically mild and dose-dependent. Starting at 0.25 mg and titrating slowly significantly reduces this. Diarrhea, constipation, and headache are also common. Rare but serious events include acute pancreatitis and acute kidney injury from dehydration. See our GLP-1 side effect management guide for titration protocols and practical strategies.
Who Each Medication Is (and Isn't) For
Phentermine May Be Considered When:
- Short-term appetite suppression is the primary goal
- No cardiovascular history, uncontrolled hypertension, or hyperthyroidism
- Patient is not on MAOIs
- A licensed provider has assessed and cleared the cardiovascular risk profile
Semaglutide May Be Considered When:
- Long-term, sustained weight management is the goal
- Patient has insulin resistance or prediabetes (dual benefit)
- Weekly dosing is manageable
- No personal or family history of medullary thyroid carcinoma
Can You Combine Phentermine and Semaglutide?
Some clinical practices have used both in select patients who plateau on GLP-1 therapy alone. This is off-label, not first-line, and requires a thorough cardiovascular evaluation before initiation. Any combination approach is subject to medical approval by a licensed provider based on individual health history — it is not appropriate for everyone.
Which Should You Consider?
For most people seeking sustainable weight management with a strong evidence base, compounded semaglutide through a supervised telehealth program offers significantly better long-term outcomes than phentermine. Phentermine may have a role in specific short-term clinical contexts — always under active provider supervision and monitoring.
Neither medication works in isolation. Diet quality, sleep, stress management, and resistance training determine outcomes regardless of which drug is prescribed. A licensed provider evaluation gives you the right starting point. TelosRX connects you with licensed providers through an asynchronous telehealth process — no synchronous call required.
Frequently Asked Questions
What is the main difference between phentermine and semaglutide?
Phentermine is a stimulant that suppresses appetite by triggering norepinephrine release in the brain. Semaglutide is a GLP-1 receptor agonist that slows digestion, reduces hunger through multiple pathways, and improves insulin sensitivity. The mechanisms, evidence base, and appropriate duration of use are substantially different.
Does semaglutide produce more weight loss than phentermine?
Yes, in clinical evidence. The STEP 1 trial showed average weight loss of 14.9% of body weight over 68 weeks with semaglutide 2.4 mg. Phentermine trials typically show 5–10% over shorter periods. Semaglutide's advantage grows the longer treatment continues.
Can you take phentermine and semaglutide together?
Some providers use both in patients who have plateaued on GLP-1 therapy. This is off-label, not first-line, and requires a thorough cardiovascular evaluation. It is subject to medical approval by a licensed provider for each individual case — not appropriate for everyone.
Is compounded semaglutide the same as Wegovy?
Compounded semaglutide uses the same active ingredient as Wegovy but is not FDA-approved as a finished drug product. It is prepared under federal compounding regulations and is subject to medical evaluation before prescribing. Not the same regulatory category as the branded Wegovy product.
Which medication has more serious side effects?
Phentermine's cardiovascular side effects — elevated heart rate, blood pressure changes, and rare cardiac events — are generally considered more serious for most populations. Semaglutide's side effects are primarily GI symptoms and are manageable with slow dose titration for most patients.
Is phentermine approved for long-term use?
Phentermine was approved for chronic weight management in 2012, but long-term safety data remains limited compared to semaglutide. Its stimulant mechanism raises cardiovascular concerns in patients with underlying heart conditions. Extended use requires active provider oversight and cardiovascular monitoring.
How does semaglutide's hunger control differ from phentermine's?
Semaglutide acts on GLP-1 receptors in both the gut and the brain's reward center, reducing hunger, slowing gastric emptying, and altering food preferences. Phentermine works solely through central norepinephrine release. Semaglutide's multi-pathway effect tends to produce sustained hunger reduction; phentermine's effect often fades with tolerance.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.